NCT04374877 2025-11-10Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid TumorsCoherus Oncology, Inc.Phase 1 Completed145 enrolled
NCT04696055 2025-05-13Regorafenib Plus Pembrolizumab in Patients With Advanced or Spreading Liver Cancer Who Have Been Previously Treated With PD-1/PD-L1 Immune Checkpoint InhibitorsBayerPhase 2 Completed95 enrolled 14 charts
NCT03329950 2024-03-28A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced MalignanciesCelldex TherapeuticsPhase 1 Completed132 enrolled
NCT03111732 2021-12-03Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC)National Institutes of Health Clinical Center (CC)Phase 2 Completed11 enrolled 16 charts